ADAM28 and non-small cell lung carcinoma: Overexpression of ADAM28 by carcinoma cells has been described in a wide range of cancers including breast cancer, chondrosarcoma [6], head and neck carcinoma [7], B-cell acute lymphoblastic leukemia [8], bladder carcinoma [9], non-small cell lung carcinoma (NSCLC) [10] and prostate cancer [11].